Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients

CONCLUSIONS: This study showed that 15.6% of anti-SARS-CoV-2 ELISA positive Croatian SOTRs developed NT antibodies indicating protective immunity. Further studies are needed to determine the dynamic of NT antibodies and COVID-19 immunity duration in immunocompromised populations such as LTRs and KTRs.PMID:34658649 | PMC:PMC8495621 | DOI:10.11613/BM.2021.030901
Source: Biochemia Medica - Category: Biochemistry Authors: Source Type: research